Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Lutters, BCH; Meijers, JCM; Derksen, RHWM; Arnout, J; de Groot, PG
   Dimers of beta(2)-glycoprotein I mimic the in vitro effects of beta(2)-glycoprotein I-anti-beta(2)-glycoprotein I antibody complexes
   JOURNAL OF BIOLOGICAL CHEMISTRY
   
   B.C.H. Lutters et al., "Dimers of beta(2)-glycoprotein I mimic the in vitro effects of beta(2)-glycoprotein I-anti-beta(2)-glycoprotein I antibody complexes", J BIOL CHEM, 276(5), 2001, pp. 3060-3067
2. Frijns, CJM; Derksen, RHWM; De Groot, PG; Algra, A; Fijnheer, R
   Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus
   CLINICAL AND EXPERIMENTAL IMMUNOLOGY
   
   C.J.M. Frijns et al., "Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus", CLIN EXP IM, 125(1), 2001, pp. 149-154
3. Simmelink, MJA; Horbach, DA; Derksen, RHWM; Meijers, JCM; Bevers, EM; Willems, GM; De Groot, PG
   Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces
   BRITISH JOURNAL OF HAEMATOLOGY
   
   M.J.A. Simmelink et al., "Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces", BR J HAEM, 113(3), 2001, pp. 621-629
4. Derksen, RHWM; De Groot, PG; Nieuwenhuis, HK; Christiaens, GCML
   Treatment of women with aPL in pregnancy - Reply
   ANNALS OF THE RHEUMATIC DISEASES
   
   R.H.W.M. Derksen et al., "Treatment of women with aPL in pregnancy - Reply", ANN RHEUM D, 60(7), 2001, pp. 718-718
5. Derksen, RHWM; de Groot, G; Nieuwenhuis, HK; Christiaens, GCML
   How to treat women with antiphospholipid antibodies in pregnancy?
   ANNALS OF THE RHEUMATIC DISEASES
   
   R.H.W.M. Derksen et al., "How to treat women with antiphospholipid antibodies in pregnancy?", ANN RHEUM D, 60(1), 2001, pp. 1-3
6. de Groot, PG; Bouma, B; Lutters, BCH; Simmelink, MJA; Derksen, RHWM; Gros, P
   Structure-function studies on beta 2-glycoprotein I
   JOURNAL OF AUTOIMMUNITY
   
   P.G. de Groot et al., "Structure-function studies on beta 2-glycoprotein I", J AUTOIMMUN, 15(2), 2000, pp. 87-89
7. Derksen, RHWM; de Groot, PG
   Do we know which patients with the antiphospholipid syndrome should receive long-term high dose anti-coagulation?
   JOURNAL OF AUTOIMMUNITY
   
   R.H.W.M. Derksen e P.G. de Groot, "Do we know which patients with the antiphospholipid syndrome should receive long-term high dose anti-coagulation?", J AUTOIMMUN, 15(2), 2000, pp. 255-259
8. de Groot, PG; Bouma, B; Lutters, BCH; Derksen, RHWM
   Lupus anticoagulant in cardiovascular diseases: the role of beta(2)-glycoprotein I
   ANNALS OF MEDICINE
   
   P.G. de Groot et al., "Lupus anticoagulant in cardiovascular diseases: the role of beta(2)-glycoprotein I", ANN MED, 32, 2000, pp. 32-36
9. Dijstelbloem, HM; Bijl, M; Fijnheer, R; Scheepers, RHM; Oost, WW; Jansen, MD; Sluiter, WJ; Limburg, PC; Derksen, RHWM; van de Winkel, JGJ; Kallenberg, CGM
   Fc gamma receptor polymorphisms in systemic lupus erythematosus - Association with disease and in vivo clearance of immune complexes
   ARTHRITIS AND RHEUMATISM
   
   H.M. Dijstelbloem et al., "Fc gamma receptor polymorphisms in systemic lupus erythematosus - Association with disease and in vivo clearance of immune complexes", ARTH RHEUM, 43(12), 2000, pp. 2793-2800
10. de Groot, PG; Derksen, RHWM
    The influence of antiphospholipid antibodies on the protein C pathway
    HUGHES SYNDROME: ANTIPHOSPHOLIPID SYNDROME
    
    P.G. de Groot e R.H.W.M. Derksen, "The influence of antiphospholipid antibodies on the protein C pathway", HUGHES SYNDROME: ANTIPHOSPHOLIPID SYNDROME, 2000, pp. 307-316
11. Horbach, DA; van Oort, E; Lisman, T; Meijers, JCM; Derksen, RHWM; de Groot, PG
    beta(2)-glycoprotein I is proteolytically cleaved in vivo upon activation of fibrinolysis
    THROMBOSIS AND HAEMOSTASIS
    
    D.A. Horbach et al., "beta(2)-glycoprotein I is proteolytically cleaved in vivo upon activation of fibrinolysis", THROMB HAEM, 81(1), 1999, pp. 87-95
12. Bouma, B; de Groot, PG; van den Elsen, JMH; Ravelli, RBG; Schouten, A; Simmelink, MJA; Derksen, RHWM; Kroon, J; Gros, P
    Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure
    EMBO JOURNAL
    
    B. Bouma et al., "Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure", EMBO J, 18(19), 1999, pp. 5166-5174
13. DEGROOT PG; HORBACH DA; SIMMELINK MJA; VANOORT E; DERKSEN RHWM
    ANTI-PROTHROMBIN ANTIBODIES AND THEIR RELATION WITH THROMBOSIS AND LUPUS ANTICOAGULANT
    Lupus
    
    P.G. Degroot et al., "ANTI-PROTHROMBIN ANTIBODIES AND THEIR RELATION WITH THROMBOSIS AND LUPUS ANTICOAGULANT", Lupus, 7, 1998, pp. 32-36
14. HORBACH DA; VANOORT E; TEMPELMAN MJ; DERKSEN RHWM; DEGROOT PG
    THE PREVALENCE OF A NON-PHOSPHOLIPID-BINDING FORM OF BETA(2)-GLYCOPROTEIN-I IN HUMAN PLASMA
    Thrombosis and haemostasis
    
    D.A. Horbach et al., "THE PREVALENCE OF A NON-PHOSPHOLIPID-BINDING FORM OF BETA(2)-GLYCOPROTEIN-I IN HUMAN PLASMA", Thrombosis and haemostasis, 80(5), 1998, pp. 791-797
15. HORBACH DA; VANOORT E; DERKSEN RHWM; DEGROOT PG
    THE CONTRIBUTION OF ANTI-PROTHROMBIN-ANTIBODIES TO LUPUS ANTICOAGULANT ACTIVITY - DISCRIMINATION BETWEEN FUNCTIONAL AND NONFUNCTIONAL ANTI-PROTHROMBIN-ANTIBODIES
    Thrombosis and haemostasis
    
    D.A. Horbach et al., "THE CONTRIBUTION OF ANTI-PROTHROMBIN-ANTIBODIES TO LUPUS ANTICOAGULANT ACTIVITY - DISCRIMINATION BETWEEN FUNCTIONAL AND NONFUNCTIONAL ANTI-PROTHROMBIN-ANTIBODIES", Thrombosis and haemostasis, 79(4), 1998, pp. 790-795
16. FIJNHEER R; ROEST M; HAAS FJLM; DEGROOT PG; DERKSEN RHWM
    HOMOCYSTEINE, METHYLENETETRAHYDROFOLATE REDUCTASE POLYMORPHISM, ANTIPHOSPHOLIPID ANTIBODIES, AND THROMBOEMBOLIC EVENTS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A RETROSPECTIVE COHORT STUDY
    Journal of rheumatology
    
    R. Fijnheer et al., "HOMOCYSTEINE, METHYLENETETRAHYDROFOLATE REDUCTASE POLYMORPHISM, ANTIPHOSPHOLIPID ANTIBODIES, AND THROMBOEMBOLIC EVENTS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A RETROSPECTIVE COHORT STUDY", Journal of rheumatology, 25(9), 1998, pp. 1737-1742
17. DERKSEN RHWM
    DEHYDROEPIANDROSTERONE (DHEA) AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    Seminars in arthritis and rheumatism
    
    R.H.W.M. Derksen, "DEHYDROEPIANDROSTERONE (DHEA) AND SYSTEMIC LUPUS-ERYTHEMATOSUS", Seminars in arthritis and rheumatism, 27(6), 1998, pp. 335-347
18. DONDERS RCJM; KAPPELLE LJ; DERKSEN RHWM; ALGRA A; HORBACH DA; DEGROOT PG; VANGIJN J
    TRANSIENT MONOCULAR BLINDNESS AND ANTIPHOSPHOLIPID ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    Neurology
    
    R.C.J.M. Donders et al., "TRANSIENT MONOCULAR BLINDNESS AND ANTIPHOSPHOLIPID ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS", Neurology, 51(2), 1998, pp. 535-540
19. VANVUGT RM; DERKSEN RHWM; KATER L; BIJLSMA JWJ
    DEFORMING ARTHROPATHY OR LUPUS AND RHUPUS HANDS IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    Annals of the Rheumatic Diseases
    
    R.M. Vanvugt et al., "DEFORMING ARTHROPATHY OR LUPUS AND RHUPUS HANDS IN SYSTEMIC LUPUS-ERYTHEMATOSUS", Annals of the Rheumatic Diseases, 57(9), 1998, pp. 540-544
20. DERKSEN RHWM
    VASOOCCLUSIVE RETINOPATHY - IS IT A CLASSICAL CLINICAL MANIFESTATION OF THE ANTIPHOSPHOLIPID SYNDROME - REPLY
    Lupus
    
    R.H.W.M. Derksen, "VASOOCCLUSIVE RETINOPATHY - IS IT A CLASSICAL CLINICAL MANIFESTATION OF THE ANTIPHOSPHOLIPID SYNDROME - REPLY", Lupus, 6(7), 1997, pp. 618-618
21. HORBACH DA; VANOORT E; DERKSEN RHWM; DEGROOT PG
    ANTIPROTHROMBIN ANTIBODIES DO NOT NECESSARILY CAUSE LUPUS ANTICOAGULANT ACTIVITY
    Thrombosis and haemostasis
    
    D.A. Horbach et al., "ANTIPROTHROMBIN ANTIBODIES DO NOT NECESSARILY CAUSE LUPUS ANTICOAGULANT ACTIVITY", Thrombosis and haemostasis, 1997, pp. 2198-2198
22. BOOTSMA H; DERKSEN RHWM; JAEGERS SMHJ; SPRONK PE; BIJL M; KATER L; KALLENBERG CGM
    USEFULNESS OF THE SLICC ACR DAMAGE INDEX IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS/
    Arthritis and rheumatism
    
    H. Bootsma et al., "USEFULNESS OF THE SLICC ACR DAMAGE INDEX IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS/", Arthritis and rheumatism, 40(9), 1997, pp. 775-775
23. KALLENBERG CGM; BOOTSMA H; SPRONK PE; TERBORG EJ; DERKSEN RHWM; KATER L
    LABORATORY TESTS AS PREDICTORS OF FLARES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - COMMENT
    Arthritis and rheumatism
    
    C.G.M. Kallenberg et al., "LABORATORY TESTS AS PREDICTORS OF FLARES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - COMMENT", Arthritis and rheumatism, 40(2), 1997, pp. 393-393
24. DEGROOT PG; HORBACH DA; DERKSEN RHWM
    PROTEIN-C AND OTHER COFACTORS INVOLVED IN THE BINDING OF ANTIPHOSPHOLIPID ANTIBODIES - RELATION TO THE PATHOGENESIS OF THROMBOSIS
    Lupus
    
    P.G. Degroot et al., "PROTEIN-C AND OTHER COFACTORS INVOLVED IN THE BINDING OF ANTIPHOSPHOLIPID ANTIBODIES - RELATION TO THE PATHOGENESIS OF THROMBOSIS", Lupus, 5(5), 1996, pp. 488-493
25. DERKSEN RHWM
    CLINICAL MANIFESTATIONS AND MANAGEMENT OF THE ANTIPHOSPHOLIPID SYNDROME
    Lupus
    
    R.H.W.M. Derksen, "CLINICAL MANIFESTATIONS AND MANAGEMENT OF THE ANTIPHOSPHOLIPID SYNDROME", Lupus, 5(2), 1996, pp. 167-169
26. DERKSEN RHWM; GMELIGMEIJLING FHJ; DEGROOT PG
    PRIMARY ANTIPHOSPHOLIPID SYNDROME EVOLVING INTO SYSTEMIC LUPUS-ERYTHEMATOSUS
    Lupus
    
    R.H.W.M. Derksen et al., "PRIMARY ANTIPHOSPHOLIPID SYNDROME EVOLVING INTO SYSTEMIC LUPUS-ERYTHEMATOSUS", Lupus, 5(1), 1996, pp. 77-80
27. HORBACH DA; VANOORT E; DONDERS RCJM; DERKSEN RHWM; DEGROOT PG
    LUPUS ANTICOAGULANT IS THE STRONGEST RISK FACTOR FOR BOTH VENOUS AND ARTERIAL THROMBOSIS IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - COMPARISON BETWEEN DIFFERENT ASSAYS FOR THE DETECTION OF ANTIPHOSPHOLIPID ANTIBODIES
    Thrombosis and haemostasis
    
    D.A. Horbach et al., "LUPUS ANTICOAGULANT IS THE STRONGEST RISK FACTOR FOR BOTH VENOUS AND ARTERIAL THROMBOSIS IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - COMPARISON BETWEEN DIFFERENT ASSAYS FOR THE DETECTION OF ANTIPHOSPHOLIPID ANTIBODIES", Thrombosis and haemostasis, 76(6), 1996, pp. 916-924
28. FIJNHEER R; HORBACH DA; DONDERS RCJM; VILE H; VONOORT E; NIEUWENHUIS HK; GMELIGMEIJLING FHJ; DEGROOT PG; DERKSEN RHWM
    FACTOR-V LEIDEN, ANTIPHOSPHOLIPID ANTIBODIES AND THROMBOSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    Thrombosis and haemostasis
    
    R. Fijnheer et al., "FACTOR-V LEIDEN, ANTIPHOSPHOLIPID ANTIBODIES AND THROMBOSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS", Thrombosis and haemostasis, 76(4), 1996, pp. 514-517
29. BOOTSMA H; SPRONK PE; LIMBURG PC; MEYLING FHJG; KATER L; DERKSEN RHWM; KALLENBERG CGM
    COMPARISON OF SENSITIVITY TO CHANGE OF 2 CLINICAL MEASURES OF LUPUS DISEASE-ACTIVITY - A LONGITUDINAL PROSPECTIVE-STUDY
    Arthritis and rheumatism
    
    H. Bootsma et al., "COMPARISON OF SENSITIVITY TO CHANGE OF 2 CLINICAL MEASURES OF LUPUS DISEASE-ACTIVITY - A LONGITUDINAL PROSPECTIVE-STUDY", Arthritis and rheumatism, 39(9), 1996, pp. 261-261
30. HORBACH DA; FIJNHEER R; VANOORT E; DONDERS RCJM; DEGROOT PG; DERKSEN RHWM
    FACTOR-V LEIDEN, ANTIPHOSPHOLIPID ANTIBODIES AND THROMBOSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    Arthritis and rheumatism
    
    D.A. Horbach et al., "FACTOR-V LEIDEN, ANTIPHOSPHOLIPID ANTIBODIES AND THROMBOSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS", Arthritis and rheumatism, 39(9), 1996, pp. 1050-1050
31. HORBACH DA; DERKSEN RHWM; DEGROOT PG
    THE PRESENCE OF ANTI-BETA(2)-GLYCOPROTEIN-I AND ANTI-PROTHROMBIN ANTIBODIES AND THEIR CORRELATIONS WITH VENOUS AND ARTERIAL THROMBOSIS
    Annales de medecine interne
    
    D.A. Horbach et al., "THE PRESENCE OF ANTI-BETA(2)-GLYCOPROTEIN-I AND ANTI-PROTHROMBIN ANTIBODIES AND THEIR CORRELATIONS WITH VENOUS AND ARTERIAL THROMBOSIS", Annales de medecine interne, 147, 1996, pp. 42-43
32. KATER L; GMELIGMEYLING FHJ; DERKSEN RHWM; DELAFAILLE HB
    IMMUNOPATHOGENESIS AND THERAPY OF SYSTEMIC LUPUS-ERYTHEMATOSUS
    CLINICAL IMMUNOTHERAPEUTICS
    
    L. Kater et al., "IMMUNOPATHOGENESIS AND THERAPY OF SYSTEMIC LUPUS-ERYTHEMATOSUS", CLINICAL IMMUNOTHERAPEUTICS, 4(6), 1995, pp. 471-493
33. VANHEERDE WL; DEGROOT PG; DERKSEN RHWM; FREYSSINET JM; VROOM TM; REUTELINGSPERGER CPM
    ANNEXIN-V IS HIGHLY ABUNDANT IN CELLS WHICH POSSESS A BARRIER FUNCTION BETWEEN BLOOD AND TISSUE AND CIRCULATES IN PLASMAS OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    Thrombosis and haemostasis
    
    W.L. Vanheerde et al., "ANNEXIN-V IS HIGHLY ABUNDANT IN CELLS WHICH POSSESS A BARRIER FUNCTION BETWEEN BLOOD AND TISSUE AND CIRCULATES IN PLASMAS OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS", Thrombosis and haemostasis, 73(6), 1995, pp. 1265-1265
34. VANHEERDE WL; DEGROOT PG; DERKSEN RHWM; FREYSSINET JM; REUTELINGSPERGER CPM
    ELEVATED ANNEXIN-V LEVELS IN PLASMAS OF PATIENTS WITH AUTOIMMUNE-DISEASES
    Blood
    
    W.L. Vanheerde et al., "ELEVATED ANNEXIN-V LEVELS IN PLASMAS OF PATIENTS WITH AUTOIMMUNE-DISEASES", Blood, 86(10), 1995, pp. 3549-3549
35. DUITS AJ; BOOTSMA H; DERKSEN RHWM; SPRONK PE; KATER L; KALLENBERG CGM; CAPEL PJA; WESTERDAAL NAC; SPIERENBURG GT; GMELIGMEYLING FHJ; VANDEWINKEL JGJ
    SKEWED DISTRIBUTION OF IGG FC RECEPTOR IIA (CD32) POLYMORPHISM IS ASSOCIATED WITH RENAL-DISEASE IN SYSTEMIC LUPUS-ERYTHEMATOSUS PATIENTS
    Arthritis and rheumatism
    
    A.J. Duits et al., "SKEWED DISTRIBUTION OF IGG FC RECEPTOR IIA (CD32) POLYMORPHISM IS ASSOCIATED WITH RENAL-DISEASE IN SYSTEMIC LUPUS-ERYTHEMATOSUS PATIENTS", Arthritis and rheumatism, 38(12), 1995, pp. 1832-1836
36. DEGROOT PG; DERKSEN RHWM
    PROTEIN-C PATHWAY, ANTIPHOSPHOLIPID ANTIBODIES AND THROMBOSIS
    Lupus
    
    P.G. Degroot e R.H.W.M. Derksen, "PROTEIN-C PATHWAY, ANTIPHOSPHOLIPID ANTIBODIES AND THROMBOSIS", Lupus, 3(4), 1994, pp. 229-233
37. DERKSEN RHWM; BRUINSE HW; DEGROOT PG; KATER L
    PREGNANCY IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A PROSPECTIVE-STUDY
    Lupus
    
    R.H.W.M. Derksen et al., "PREGNANCY IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A PROSPECTIVE-STUDY", Lupus, 3(3), 1994, pp. 149-155
38. DERKSEN RHWM; DEGROOT PG; KATER L
    ANTIPHOSPHOLIPID ANTIBODIES AND VASCULAR PATHOLOGY
    Netherlands journal of medicine
    
    R.H.W.M. Derksen et al., "ANTIPHOSPHOLIPID ANTIBODIES AND VASCULAR PATHOLOGY", Netherlands journal of medicine, 45(6), 1994, pp. 257-261
39. BAKE AWLV; BERDEN JHM; DERKSEN RHWM; DEGLASVOS JW; HAGEN EC
    THERAPY OF PROLIFERATIVE LUPUS GLOMERULONEPHRITIS - A PROSPECTIVE TRIAL IN THE NETHERLANDS
    Netherlands journal of medicine
    
    A.W.L.V. Bake et al., "THERAPY OF PROLIFERATIVE LUPUS GLOMERULONEPHRITIS - A PROSPECTIVE TRIAL IN THE NETHERLANDS", Netherlands journal of medicine, 45(6), 1994, pp. 280-284
40. DERKSEN RHWM; DEGROOT PG; KATER L; NIEUWENHUIS HK
    LONG-TERM ANTICOAGULANT TREATMENT IN THE ANTIPHOSPHOLIPID SYNDROME - REPLY
    Annals of the Rheumatic Diseases
    
    R.H.W.M. Derksen et al., "LONG-TERM ANTICOAGULANT TREATMENT IN THE ANTIPHOSPHOLIPID SYNDROME - REPLY", Annals of the Rheumatic Diseases, 53(5), 1994, pp. 355-355
41. DEGROOT PG; OOSTING JD; DERKSEN RHWM
    ANTIPHOSPHOLIPID ANTIBODIES - SPECIFICITY AND PATHOPHYSIOLOGY
    Bailliere's clinical haematology
    
    P.G. Degroot et al., "ANTIPHOSPHOLIPID ANTIBODIES - SPECIFICITY AND PATHOPHYSIOLOGY", Bailliere's clinical haematology, 6(3), 1993, pp. 691-709
42. OOSTING JD; DERKSEN RHWM; BOBBINK IWG; HACKENG TM; BOUMA BN; DEGROOT PG
    ANTIPHOSPHOLIPID ANTIBODIES DIRECTED AGAINST A COMBINATION OF PHOSPHOLIPIDS WITH PROTHROMBIN, PROTEIN-C OR PROTEIN-S - AN EXPLANATION FOR THEIR PATHOGENIC MECHANISM
    Thrombosis and haemostasis
    
    J.D. Oosting et al., "ANTIPHOSPHOLIPID ANTIBODIES DIRECTED AGAINST A COMBINATION OF PHOSPHOLIPIDS WITH PROTHROMBIN, PROTEIN-C OR PROTEIN-S - AN EXPLANATION FOR THEIR PATHOGENIC MECHANISM", Thrombosis and haemostasis, 69(6), 1993, pp. 1012-1012
43. OOSTING JD; PREISSNER KT; DERKSEN RHWM; DEGROOT PG
    AUTOANTIBODIES DIRECTED AGAINST THE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS OF THROMBOMODULIN INHIBIT PROTEIN-C ACTIVATION IN-VITRO
    British Journal of Haematology
    
    J.D. Oosting et al., "AUTOANTIBODIES DIRECTED AGAINST THE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS OF THROMBOMODULIN INHIBIT PROTEIN-C ACTIVATION IN-VITRO", British Journal of Haematology, 85(4), 1993, pp. 761-768
44. OOSTING JD; DERKSEN RHWM; BOBBINK IWG; HACKENG TM; BOUMA BN; DEGROOT PG
    ANTIPHOSPHOLIPID ANTIBODIES DIRECTED AGAINST A COMBINATION OF PHOSPHOLIPIDS WITH PROTHROMBIN, PROTEIN-C, OR PROTEIN-S - AN EXPLANATION FOR THEIR PATHOGENIC MECHANISM
    Blood
    
    J.D. Oosting et al., "ANTIPHOSPHOLIPID ANTIBODIES DIRECTED AGAINST A COMBINATION OF PHOSPHOLIPIDS WITH PROTHROMBIN, PROTEIN-C, OR PROTEIN-S - AN EXPLANATION FOR THEIR PATHOGENIC MECHANISM", Blood, 81(10), 1993, pp. 2618-2625
45. DERKSEN RHWM; DEGROOT PG; NIEUWENHUIS HK; KATER L
    PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES AND VENOUS THROMBOSIS SHOULD RECEIVE LONG-TERM ANTICOAGULATION
    Arthritis and rheumatism
    
    R.H.W.M. Derksen et al., "PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES AND VENOUS THROMBOSIS SHOULD RECEIVE LONG-TERM ANTICOAGULATION", Arthritis and rheumatism, 36(9), 1993, pp. 190000273-190000273
46. DERKSEN RHWM; DEGROOT PG; KATER L; NIEUWENHUIS HK
    PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES AND VENOUS THROMBOSIS SHOULD RECEIVE LONG-TERM ANTICOAGULANT TREATMENT
    Annals of the Rheumatic Diseases
    
    R.H.W.M. Derksen et al., "PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES AND VENOUS THROMBOSIS SHOULD RECEIVE LONG-TERM ANTICOAGULANT TREATMENT", Annals of the Rheumatic Diseases, 52(9), 1993, pp. 689-692